Why the study?
Does a single dose of reconstituted HDL delivered after myocardial ischemia improve cardiac glucose uptake and function in mice?
Population
Metabolically normal and insulin-resistant mice subjected to myocardial ischemia
Design
Preclinical
Authors
Loading...
rHDL post-MI benefits in insulin-resistant mice should not change practice; leaves open human translation and needs trials.
Does a single dose of reconstituted HDL delivered after myocardial ischemia improve cardiac glucose uptake and function in mice?
Reconstituted HDL administration after myocardial ischemia improves cardiac glucose metabolism, reduces infarct size, and enhances functional recovery in mice, highlighting its potential as an adjunctive therapy for acute coronary syndromes.
Heywood et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: